PerkinElmer to Present at Baird's 2020 Virtual Global Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 19, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Baird’s 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 8:30 a.m. ET. Jamey Mock, senior vice president and chief financial officer for PerkinElmer, will provide... Read more

Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*

Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System* CARLSBAD, Calif., Aug. 19, 2020 /PRNewswire/ — In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion... Read more

Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19

REGN-COV2 is Regeneron’s two-antibody combination currently in late-stage clinical trials for the treatment and prevention of COVID-19 infection. The companies will collaborate on developing and manufacturing REGN-COV2. Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S. Under this collaboration, the overall capacity of REGN-COV2 is expected to... Read more

QIAGEN expands integrated coronavirus NGS and software solutions to accelerate COVID-19 research  

Hilden, Germany, and Germantown, Maryland, August 18, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with integrated analysis and interpretation workflows for insights into the evolution and spread of the virus that causes COVID-19 disease. The new... Read more

Swift Biosciences Expands Coronavirus Research With ACE2 Swift Normalase Amplicon Panel

(ANN ARBOR, MICH.  August 17, 2020) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing... Read more

PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection

Enables Labs to Quickly Ramp up Testing Capacity and Generate Results Faster WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 17, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day.... Read more

New, Easy-to-Use, Compact, Ion Chromatography System Simplifies Water Analysis

Thermo Scientific Dionex Easion Ion Chromatography System makes everyday ion analysis simpler, while reducing total cost of ownership and need for maintenance SUNNYVALE, Calif., Aug. 17, 2020 /PRNewswire/ — Small environmental and academic teaching laboratories specializing in water analysis can benefit from simpler setup and operation and improved quality with a new, compact ion chromatography (IC)... Read more

PerkinElmer Enhances Hand Sanitizer Analyzer to Detect Methanol in 30 Seconds or Less

Instrument also tests ethanol and isopropanol concentrations to confirm product efficacy WALTHAM, Mass. – August 17, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail... Read more

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc. Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary... Read more